370 related articles for article (PubMed ID: 18482557)
1. Initial lessons learned in HPV vaccination.
Herzog TJ; Huh WK; Downs LS; Smith JS; Monk BJ
Gynecol Oncol; 2008 May; 109(2 Suppl):S4-11. PubMed ID: 18482557
[TBL] [Abstract][Full Text] [Related]
2. Understanding and overcoming barriers to human papillomavirus vaccine acceptance.
Zimet GD
Curr Opin Obstet Gynecol; 2006 Feb; 18 Suppl 1():s23-8. PubMed ID: 16520681
[TBL] [Abstract][Full Text] [Related]
3. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
Adams M; Jasani B; Fiander A
Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
[TBL] [Abstract][Full Text] [Related]
4. Improving adolescent health: focus on HPV vaccine acceptance.
Zimet GD
J Adolesc Health; 2005 Dec; 37(6 Suppl):S17-23. PubMed ID: 16310137
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with intention-to-recommend human papillomavirus vaccination among physicians in Mysore, India.
Krupp K; Marlow LA; Kielmann K; Doddaiah N; Mysore S; Reingold AL; Madhivanan P
J Adolesc Health; 2010 Apr; 46(4):379-84. PubMed ID: 20307828
[TBL] [Abstract][Full Text] [Related]
6. Preventing cervical cancer through human papillomavirus vaccination: perspective from focus groups.
Wong LP
J Low Genit Tract Dis; 2009 Apr; 13(2):85-93. PubMed ID: 19387128
[TBL] [Abstract][Full Text] [Related]
7. Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening.
Arbyn M; Dillner J
J Clin Virol; 2007 Mar; 38(3):189-97. PubMed ID: 17258503
[TBL] [Abstract][Full Text] [Related]
8. Acceptability of human papillomavirus vaccination among Chinese women: concerns and implications.
Kwan TT; Chan KK; Yip AM; Tam KF; Cheung AN; Lo SS; Lee PW; Ngan HY
BJOG; 2009 Mar; 116(4):501-10. PubMed ID: 19250361
[TBL] [Abstract][Full Text] [Related]
9. Attitudes toward HPV vaccination among parents of adolescent girls in Mysore, India.
Madhivanan P; Krupp K; Yashodha MN; Marlow L; Klausner JD; Reingold AL
Vaccine; 2009 Aug; 27(38):5203-8. PubMed ID: 19596420
[TBL] [Abstract][Full Text] [Related]
10. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.
Jenkins D
Gynecol Oncol; 2008 Sep; 110(3 Suppl 1):S18-25. PubMed ID: 18653221
[TBL] [Abstract][Full Text] [Related]
11. Clinical perspectives on the role of the human papillomavirus vaccine in the prevention of cancer.
Julius JM; Ramondeta L; Tipton KA; Lal LS; Schneider K; Smith JA
Pharmacotherapy; 2011 Mar; 31(3):280-97. PubMed ID: 21361739
[TBL] [Abstract][Full Text] [Related]
12. Women's knowledge about human papillomavirus and their acceptance of HPV vaccine.
Dursun P; Altuntas B; Kuscu E; Ayhan A
Aust N Z J Obstet Gynaecol; 2009 Apr; 49(2):202-6. PubMed ID: 19432612
[TBL] [Abstract][Full Text] [Related]
13. Young adults and acceptance of the human papillomavirus vaccine.
Lenselink CH; Schmeink CE; Melchers WJ; Massuger LF; Hendriks JC; van Hamont D; Bekkers RL
Public Health; 2008 Dec; 122(12):1295-301. PubMed ID: 18619631
[TBL] [Abstract][Full Text] [Related]
14. Overcoming the barriers to HPV vaccination in high-risk populations in the US.
Downs LS; Scarinci I; Einstein MH; Collins Y; Flowers L
Gynecol Oncol; 2010 Jun; 117(3):486-90. PubMed ID: 20303156
[TBL] [Abstract][Full Text] [Related]
15. Parental acceptance of human papillomavirus (HPV) vaccination in Indonesia: a cross-sectional study.
Jaspers L; Budiningsih S; Wolterbeek R; Henderson FC; Peters AA
Vaccine; 2011 Oct; 29(44):7785-93. PubMed ID: 21821079
[TBL] [Abstract][Full Text] [Related]
16. Adolescents' awareness of HPV infections and attitudes towards HPV vaccination 3 years following the introduction of the HPV vaccine in Hungary.
Marek E; Dergez T; Rebek-Nagy G; Kricskovics A; Kovacs K; Bozsa S; Kiss I; Ember I; Gocze P
Vaccine; 2011 Nov; 29(47):8591-8. PubMed ID: 21939711
[TBL] [Abstract][Full Text] [Related]
17. Harnessing the power of prevention: human papillomavirus vaccines.
Mayeaux EJ
Curr Opin Obstet Gynecol; 2006 Feb; 18 Suppl 1():s15-21. PubMed ID: 16520680
[TBL] [Abstract][Full Text] [Related]
18. HPV vaccine: A comparison of attitudes and behavioral perspectives between Latino and non-Latino women.
Watts LA; Joseph N; Wallace M; Rauh-Hain JA; Muzikansky A; Growdon WB; del Carmen MG
Gynecol Oncol; 2009 Mar; 112(3):577-82. PubMed ID: 19150120
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus vaccination of males: attitudes and perceptions of physicians who vaccinate females.
Weiss TW; Zimet GD; Rosenthal SL; Brenneman SK; Klein JD
J Adolesc Health; 2010 Jul; 47(1):3-11. PubMed ID: 20547286
[TBL] [Abstract][Full Text] [Related]
20. Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine.
Monsonego J; Cortes J; Greppe C; Hampl M; Joura E; Singer A
Vaccine; 2010 Nov; 28(51):8065-72. PubMed ID: 20971114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
